Introduction
At The Retina Clinic London, we are dedicated to advancing retinal care through cutting-edge research and clinical innovation. We actively collaborate with the pharmaceutical industry to bring the latest treatments to patients, ensuring that individuals have greater choice in their ophthalmic care.
All clinical trials conducted at our clinic have full ethics committee approvals, ensuring patient safety, ethical integrity, and scientific validity. In many of these studies, Professor Paulo Stanga serves as the Chief Investigator at a national level, overseeing the trial’s implementation across multiple sites and playing a key role in the ethics approval process.
Our clinical trials provide patients with early access to pioneering therapies, often years before they become widely available. Led by Professor Stanga and his team of world-renowned retinal specialists, we focus on developing new diagnostic techniques, advanced treatments, and surgical innovations to improve vision outcomes.
Current Clinical Trials
We are currently recruiting for clinical trials in the following conditions:
- Geographic Atrophy (GA). Dry AMD
- Wet Age-Related Macular Degeneration (Wet AMD)
- Vitreous Floaters & Opacities (VFO)
- Diabetic Retinopathy & Diabetic Maculopathy
- Gene Therapy for Inherited Retinal Diseases (including X-Linked Retinitis Pigmentosa, Usher Syndrome Type 1B, and Stargardt Disease)
If you are interested in participating in a trial, our team will guide you through the process to determine if a study is suitable for you.
Who Can Benefit from Clinical Trials?
Patients who take part in research studies may:
- Gain access to cutting-edge treatments before they become widely available.
- Receive close monitoring and specialist care throughout the study.
- Help advance medical knowledge and improve future treatment options for others.
Many of our trials focus on conditions where existing treatments are limited, such as early-stage Dry AMD, advanced Diabetic Maculopathy, and inherited retinal diseases.
Eligibility is assessed on a case-by-case basis, and participation is entirely voluntary.
How Does Participation Work?
We aim to make it as easy as possible for patients to participate in clinical trials. The process typically follows these steps:
- Speak with Our Team. If you are interested in a trial, we will discuss your condition and medical history to see if participation might be suitable for you.
- Pre-Screening (Free of Charge). Before a full screening, we may conduct a preliminary assessment to check whether you are likely to meet eligibility criteria. This avoids unnecessary time spent on further assessments if a trial is not suitable.
- Full Screening & Enrolment. If pre-screening suggests suitability, you will be invited for a full screening, including advanced imaging and diagnostic tests. If eligible, you will be formally enrolled in the study and begin treatment.
In most cases, if a condition affects both eyes, clinical trials will cover treatment for the fellow eye (e.g., Wet AMD trials often include both eyes if needed).
Clinical Trials Cover Patient Costs
We understand that attending research appointments can be challenging, so we aim to remove barriers to participation.
- Study-related expenses are fully covered, including treatments, tests, and follow-ups.
- Travel & accommodation costs are reimbursed, ensuring no financial burden for participation.
- Companion expenses are covered, so you can bring someone with you for support.
- Overnight stays are arranged where required, making participation accessible for patients travelling from further away.
Our goal is to ensure that patients who want to take part in research can do so comfortably and without added stress.
Why Choose The Retina Clinic London for Clinical Trials?
At The Retina Clinic London, research is a key part of our mission to deliver world-class retinal care. Patients choose us because of:
Global Expertise. Led by Professor Paulo Stanga and a team of leading retinal specialists, we are at the forefront of ophthalmic research.
State-of-the-Art Imaging & Diagnostics. We use the most advanced imaging technologies, including high-resolution OCT and AI-driven analysis, to ensure precise assessments.
Access to Revolutionary Treatments. Clinical trial participants receive cutting-edge therapies before they become widely available.
Personalised Care & Long-Term Monitoring. Patients benefit from regular follow-ups and individualised treatment plans.
Commitment to Innovation. We are actively involved in developing the future of retinal care, ensuring the latest advancements are available to our patients.
Find Out More
If you are interested n learning more about our clinical trials, or would like to see if you qualify for a study, contact us today.
Call us on: +44 (0)20 4548 5310
Email us at: info@theretinacliniclondon.com